Genesis Therapeutics is provide comprehensive service in all matters of technology transfer.
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in molecular generation and property prediction.